Prot #CNDO109-001: A Phase 1/2 Study of CNDO-109-Activated Allogeneic Natural Killer Cells in Patients with High Risk Acute Myeloid Leukemia in First Complete Remission (CR1)
- Frankfurt, Olga (PD/PI)
Project: Research project
Project: Research project